[1]
N. Ay, V. Alp, and Şeyhmus Kaya, “Posttransplant de novo donor specific HLA antibody monitoring and clinical outcomes: a single-center experience”, Eur Res J, vol. 7, no. 3, pp. 304–311, May 2021, doi: 10.18621/eurj.732625.